A poster session on “Health and Disease: Science, Technology, Culture and Policy Research” will take place on March 5, and submissions by students, staff and faculty are invited. The event, which aims ...
LEXINGTON, Mass.--(BUSINESS WIRE)--Dicerna Pharmaceuticals, Inc. (Nasdaq: DRNA), a leading developer of investigational ribonucleic acid interference (RNAi) therapeutics, today announced that two ...
BOSTON, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced that clinical data from the ...
You are able to gift 5 more articles this month. Anyone can access the link you share with no account required. Learn more. AUGUSTA — The Maine Center for Disease Control and Prevention has announced ...
As part of the Vignelli Center’s MEDdesign initiative, Professor Bruce Ian Meader conceived and developed a poster project for his graduate Information Design course. Each student selected a human ...
Gain Therapeutics, Inc., a clinical-stage biotechnology company, announced that it will present its lead drug candidate, GT-02287, at the International Association of Parkinsonism and Related ...
A poster session on “Health and Disease: Science Technology, Culture and Policy Research” will take place Thursday (March 5), and students, staff and faculty are invited to attend. The event will be ...
An error has occurred. Please try again. With a Lewiston Sun Journal subscription, you can gift 5 articles each month. It looks like you do not have any active ...
Founder, Chief Science Officer and Executive Chairman, Longeveron Results obtained in the Phase 2 placebo-controlled ...
An error has occurred. Please try again. With a Lewiston Sun Journal subscription, you can gift 5 articles each month. It looks like you do not have any active ...
Session: Oral Poster Presentation – Guided Poster TourSession Date: Saturday, May 10, 2025Session Time: 8:00-9:00 a.m. EST About GT-02287Gain Therapeutics’ lead drug candidate, GT-02287, is in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results